rs104886399
Positions:
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4BS2
The NM_033380.3(COL4A5):āc.3923A>Gā(p.Gln1308Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000248 in 1,209,134 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 13 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ).
Frequency
Genomes: š 0.000054 ( 0 hom., 3 hem., cov: 24)
Exomes š: 0.000022 ( 0 hom. 10 hem. )
Consequence
COL4A5
NM_033380.3 missense
NM_033380.3 missense
Scores
3
5
9
Clinical Significance
Conservation
PhyloP100: 1.19
Genes affected
COL4A5 (HGNC:2207): (collagen type IV alpha 5 chain) This gene encodes one of the six subunits of type IV collagen, the major structural component of basement membranes. Mutations in this gene are associated with X-linked Alport syndrome, also known as hereditary nephritis. Like the other members of the type IV collagen gene family, this gene is organized in a head-to-head conformation with another type IV collagen gene so that each gene pair shares a common promoter. Alternatively spliced transcript variants have been identified for this gene. [provided by RefSeq, Aug 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -5 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.3822859).
BS2
High Hemizygotes in GnomAd4 at 3 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
COL4A5 | NM_033380.3 | c.3923A>G | p.Gln1308Arg | missense_variant | 44/53 | ENST00000328300.11 | NP_203699.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
COL4A5 | ENST00000328300.11 | c.3923A>G | p.Gln1308Arg | missense_variant | 44/53 | 1 | NM_033380.3 | ENSP00000331902.7 | ||
COL4A5 | ENST00000361603.7 | c.3905A>G | p.Gln1302Arg | missense_variant | 42/51 | 2 | ENSP00000354505.2 | |||
COL4A5 | ENST00000489230.1 | n.326A>G | non_coding_transcript_exon_variant | 3/8 | 5 | |||||
COL4A5 | ENST00000510690.2 | n.417A>G | non_coding_transcript_exon_variant | 2/11 | 4 |
Frequencies
GnomAD3 genomes AF: 0.0000535 AC: 6AN: 112080Hom.: 0 Cov.: 24 AF XY: 0.0000876 AC XY: 3AN XY: 34238
GnomAD3 genomes
AF:
AC:
6
AN:
112080
Hom.:
Cov.:
24
AF XY:
AC XY:
3
AN XY:
34238
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000383 AC: 7AN: 182905Hom.: 0 AF XY: 0.0000593 AC XY: 4AN XY: 67501
GnomAD3 exomes
AF:
AC:
7
AN:
182905
Hom.:
AF XY:
AC XY:
4
AN XY:
67501
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000219 AC: 24AN: 1097054Hom.: 0 Cov.: 30 AF XY: 0.0000276 AC XY: 10AN XY: 362700
GnomAD4 exome
AF:
AC:
24
AN:
1097054
Hom.:
Cov.:
30
AF XY:
AC XY:
10
AN XY:
362700
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000535 AC: 6AN: 112080Hom.: 0 Cov.: 24 AF XY: 0.0000876 AC XY: 3AN XY: 34238
GnomAD4 genome
AF:
AC:
6
AN:
112080
Hom.:
Cov.:
24
AF XY:
AC XY:
3
AN XY:
34238
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
6
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Jan 17, 2020 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 03, 2023 | - - |
X-linked Alport syndrome Benign:1
Likely benign, no assertion criteria provided | clinical testing | Natera, Inc. | Feb 27, 2020 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Benign
DANN
Benign
DEOGEN2
Uncertain
.;T
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T;T
M_CAP
Pathogenic
D
MetaRNN
Benign
T;T
MetaSVM
Uncertain
T
MutationAssessor
Benign
.;N
PrimateAI
Uncertain
T
PROVEAN
Benign
N;N
REVEL
Uncertain
Sift
Benign
T;T
Sift4G
Benign
T;T
Polyphen
0.64
.;P
Vest4
MutPred
0.37
.;Gain of methylation at Q1302 (P = 0.0168);
MVP
MPC
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at